Kit Rapid Test Respiratory Test Kit OSOM® COVID-19 Antigen Direct Mid-Turbinate Nasal Swab Sample 40 Tests (40/KT 12KT/CS) by Sekisui Diagnostics, LLC ID 1066-40

188-1-6640
      
Stock Est. Shipping Date: 17th April 2025

Kit Rapid Test Respiratory Test Kit OSOM® COVID-19 Antigen Direct Mid-Turbinate Nasal Swab Sample 40 Tests (40/KT 12KT/CS)
Sold by: KT OF 40

 Reviews
Better together

  • Total: $0.00

Rally #188-1-6640
Sekisui Diagnostics #1066-40
OSOM® COVID-19 Antigen Rapid Test (40/KT)

Antigen Rapid Test, COVID-19, Mid-Turbinate Swab, Lateral Flow Chromatographic Immunoassay, Rx Only

Features
  • High positive percent agreement & negative percent agreement to help you reduce the risk of misdiagnosis & inappropriate treatment
  • Can be performed in a CLIA-waived setting & comes with everything you need to run a test, without the need for specialized equipment
  • Get results to your patient in only 15 minutes
  • Direct Mid-Turbinate nasal swab to help you improve patient comfort
  • Proudly made in the USA & backed by a trustworthy supply chain so you can avoid delays from international shipments
The OSOM® COVID-19 Antigen Rapid Test is a lateral flow chromatographic immunoassay intended for the qualitative detection of the SARS-CoV-2 nucleocapsid protein antigen in direct mid-turbinate (MT) nasal swab specimens collected by a healthcare provider from individuals suspected of COVID-19 within the first 7 days of symptom onset.

All negative results are presumptive and do not rule out SARS-CoV-2 infection. Negative results should not be used as the sole basis for treatment or patient management decisions.

This test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The OSOM COVID-19 Antigen Rapid Test does not differentiate between SARS-CoV and SARSCoV-2. Results are for the identification of SARS-CoV-2 nucleocapsid protein antigen, which is generally detectable in MT nasal swab specimens during the acute phase of infection.

The OSOM COVID-19 Antigen Rapid Test is intended for use by healthcare professionals or operators who are proficient in performing tests in point of care settings.

Important Notes
  • Product is non-returnable; please make sure it is the right product before ordering.
  • Testing must be performed within 30 minutes of specimen collection.
  • For In Vitro Diagnostic Use
  • For Directly Collected Mid-turbinate Nasal Swab Specimens
  • For Use Under Emergency Use Authorization (EUA) Only
  • For more information on this product's EUA, please go to the EUA section below.
For the State of California:
Warning: This product can expose you to chemicals known to the State of California to cause cancer. For more information, go to www.P65Warnings.ca.gov.

×
Rally #188-1-6640
Manufacturer #1066-40
BrandOSOM®
ManufacturerSekisui Diagnostics
Country of OriginUnited States
ApplicationRespiratory Test Kit
Number of Tests40 Tests
Reading TypeVisual Read
Sample TypeDirect Mid-Turbinate Nasal Swab Sample
SpecialtyImmunoassay
Test FormatTest Device Format
Test Kit TypeRapid
Test MethodLateral Flow Chromatographic Immunassay
Test NameCovid-19 Antigen
Time to Results15 Minute Results
UNSPSC Code41116144
Storage Temperature15-30 °C / 59-86 °F
Positive Percent Agreement*95.1%
Negative Percent Agreement*97.0%

*Compared to RT-PCR. See IFU.


× will not be use because table provided-->
Configurations
Product ID Description Quantity
1066-40 OSOM® COVID-19 Antigen Rapid Test 40 Tests Per Kit
1068 OSOM® COVID-19 Antigen Control Kit 5 x SARS-CoV-2 Positive Control Swabs
5 x SARS-CoV2 Negative Control Swabs
×
Materials Provided in Each Test Kit
Material Description Quantity
OSOM COVID-19 Antigen Test Devices Test devices containing LFI test strip in a plastic housing 40
OSOM Antigen Buffer Tubes Nasal swab specimen collection & dispensing tube containing OSOM Antigen Buffer 2 x 20
Sterile, Nasal Swabs Mid-Turbinate Nasal Swab 40
Instructions For Use (IFU) 1
Quick Reference Guide For Direct Nasal Swab Samples 1
×


Video Links
×
Promotions are currently not available at this time. Please check back later.

×

- Reimbursements Information -

This product maybe reimbursable, depending on various factors including current law and policies. Rally Inc. does not handle these reimbursements; instead, each reimbursement is handled solely between you, the customer, and the manufacturer, SEKISUI Diagnostics LLC. Rally Inc. does not oversee these reimbursements. To check eligibility and get your reimbursements, please follow the manufacturer's reimbursements instructions.

You can find more informations on reimbursement details here.

×

EUA - Emergency Use Authorization

This test has not been FDA cleared or approved. It is authorized by FDA under an EUA for use by authorized laboratories. It has been authorized only for the detection of SARS-CoV-2 antigen, not for any other viruses or pathogens and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C S360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.